No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
270 |
4. Check minimum number of eventsNone |
270 |
5. Include endpointsNone |
270 |
6. Filter based on genotype QC (FinnGen only) |
227 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Isolated growth hormone deficiency
based on the number of shared cases.
Similar with more cases:
- Hypopituitarism
- Exclusions for E4_PCOS_BROAD
- Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT
- Disorders of other endocrine glands
- Exclusions for E4_PCOS_CONSORTIUM
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 227 | 94 | 133 |
| Unadjusted period prevalence (%) | 0.05 | 0.03 | 0.06 |
| Median age at first event (years) | 10.59 | 11.70 | 9.80 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 256
- Matched controls
- 2560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H01AC01
ATC
somatropin; parenteral
655.0
307.7
235
43
101
Kela drug reimbursment
Anterior pituitary hypofunction
1164.1
307.7
210
10
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
307.7
255
*
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
129.7
223.0
115
16
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
20.0
135.0
145
157
E34.35
ICD-10 Finland
Abnormal growth retardation
19.4
96.1
86
65
301
Kela drug reimbursment
Growth hormone
27.5
86.7
63
30
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
22.2
84.6
68
41
E23.00
ICD-10 Finland
Panhypopituitarism
676.4
56.9
54
*
H03AA01
ATC
levothyroxine sodium; systemic
7.5
44.9
79
143
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
15.1
42.7
40
31
H02AB09
ATC
hydrocortisone; systemic
7.8
40.6
66
109
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
5.4
36.9
102
279
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
61.4
32.3
37
7
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.2
29.5
76
192
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
6.8
23.9
41
70
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
227.8
20.9
21
*
E34.31
ICD-10 Finland
Short stature, prenatal disorder
23.1
19.1
27
13
602
Kela drug reimbursment
Children's severe malnutrition
5.5
18.7
40
84
E34.30
ICD-10 Finland
Short stature NOS
18.3
18.3
28
17
E23.0
ICD-10 Finland
Hypopituitarism
+∞
16.9
16
*
Z31.5
ICD-10 Finland
Genetic counselling
4.0
16.7
55
163
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
16.7
113
527
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
170.0
15.7
16
*
Z3231
NOMESCO Finland
Registered nurse
2.9
15.2
145
803
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.0
14.7
87
372
E23.05
ICD-10 Finland
Lack of TSH
158.7
14.6
15
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
6.2
14.0
25
44
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.9
13.9
46
136
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
13.9
132
720
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
13.7
49
153
E23.1
ICD-10 Finland
Drug-induced hypopituitarism
+∞
13.7
13
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.5
12.9
51
170
XCK00
NOMESCO Finland
Perimetry
10.1
12.3
24
26
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
14.3
12.2
20
15
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
24.2
11.7
16
7
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.6
11.1
28
67
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.7
11.1
79
366
Z3226
NOMESCO Finland
Physiotherapist
2.5
11.0
99
513
121
Kela drug reimbursment
Severe hypofunction of sexual glands
16.4
11.0
17
11
Z01.8
ICD-10 Finland
Other specified special examinations
2.7
10.9
73
327
ZXE00
NOMESCO Finland
One hour or less
2.4
10.9
139
842
102
Kela drug reimbursment
Diabetes insipidus
62.7
10.7
12
*
F83
ICD-10 Finland
Mixed specific developmental disorders
3.7
10.6
36
108
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
4.0
10.5
32
89
G03DB01
ATC
dydrogesterone; oral
4.6
10.4
26
62
BF20A, ,
NOMESCO Finland
27.2
9.9
13
5
T99
ICPC
Endocr/metab/nutrit disease other
15.8
9.6
15
10
G03FB08
ATC
dydrogesterone and estrogen; systemic
15.8
9.6
15
10
E22.80
ICD-10 Finland
Central precocious puberty
18.4
9.5
14
8
L02AE02
ATC
leuprorelin; implant, parenteral
11.3
9.4
17
16
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
+∞
9.4
9
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
9.2
59
257
RD210, ,
NOMESCO Finland
3.2
9.0
38
131
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
9.0
64
294
XA800
NOMESCO Finland
Neuropsychological investigation
2.8
8.8
49
198
H53.4
ICD-10 Finland
Visual field defects
13.4
8.5
14
11
E23.03
ICD-10 Finland
Lack of ACTH
93.0
8.5
9
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.0
8.2
18
38
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
7.2
8.2
19
28
Z2446
NOMESCO Finland
Social worker
2.3
7.9
71
360
H47.2
ICD-10 Finland
Optic atrophy
15.7
7.8
12
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
7.8
77
407
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
19.1
7.7
11
6
Z2445
NOMESCO Finland
Psychologist
2.5
7.6
57
267
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.0
7.5
22
59
UKC02
NOMESCO Finland
Cystoscopy
3.8
7.5
23
64
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
7.5
102
612
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
+∞
7.3
7
*
TAB00
NOMESCO Finland
Lumbar puncture
3.3
7.3
28
91
R4190
NOMESCO Finland
Nutritional therapy
2.4
7.2
57
272
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
31.0
7.2
9
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.5
7.2
25
76
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
7.1
100
604
104
Kela drug reimbursment
Thyroid insufficiency
6.7
7.1
17
27
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
6.4
6.9
17
28
Y28
ICPC
Limited function/disability (Y)
23.2
6.7
9
*
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
10.4
6.6
12
12
R4110
NOMESCO Finland
Physiotherapy
2.0
6.5
92
553
ZXC86
NOMESCO Finland
Use of endoscopic device
71.6
6.5
7
*
E23.2
ICD-10 Finland
Diabetes insipidus
71.6
6.5
7
*
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
14.8
6.4
10
7
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.6
6.4
40
171
7834C
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]
+∞
6.3
6
*
E23.08
ICD-10 Finland
Hypopituitarism
+∞
6.3
6
*
Q96.0
ICD-10 Finland
Karyotype 45,X
+∞
6.3
6
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
6.1
17
44
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
6.1
47
222
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.7
6.0
19
54
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
138
299
8.84
69.38
4.6
3.1
307.64
326.42
nmol/l
0.53
133
291
84
111
10.77
63.96
1.8
1.9
22.09
19.73
ng/l
0.58
84
111
99
222
6.64
45.65
3.3
2.4
4.26
5.15
u/l
0.76
59
129
92
213
6.18
40.52
3.2
2.5
7.00
9.67
iu/l
0.82
58
134
53
130
4.88
20.83
3.3
3.4
4.92
5.19
pmol/l
0.87
53
120
54
139
4.66
19.97
3.4
1.5
302.22
337.06
mu/l
0.42
54
131
197
1254
3.48
16.62
8.7
7.3
129.14
125.71
u/l
0.23
187
1191
110
520
2.96
15.67
13.1
14.3
1.33
1.33
mmol/l
0.12
104
494
26
51
5.56
12.98
2.6
1.5
0.22
0.44
nmol/l
0.99
20
40
236
1827
4.73
11.91
7.5
4.4
1.90
1.96
mu/l
0.32
224
1742
66
284
2.78
10.66
4.6
4.1
23.24
21.45
%
0.42
66
279
102
555
2.39
10.02
4.1
3.5
2.40
2.40
mmol/l
0.16
97
517
24
56
4.63
9.82
2.9
2.4
0.11
0.11
nmol/l
0.03
19
46
119
700
2.31
9.69
10.0
10.8
38.13
38.28
g/l
0.12
114
680
164
1109
2.33
9.50
19.8
14.4
1.22
1.22
mmol/l
0.30
150
1036
59
262
2.63
8.83
3.6
5.6
0.22
0.21
g/l
0.64
59
257
64
307
2.45
8.10
4.7
4.0
2.51
2.54
g/l
0.20
64
295
189
1468
2.10
6.34
14.1
14.4
3.45
3.52
e9/l
0.17
155
1221
137
973
1.88
5.74
1.8
2.0
0.69
4.44
u/ml
3.28
20
159
91
600
1.80
4.61
3.6
3.8
2.47
2.45
mg/l
0.05
83
547
33
153
2.33
4.41
11.3
18.7
-0.58
0.12
mmol/l
0.45
28
131
9
12
7.73
4.39
1.7
2.3
—
—
—
0
0
144
1100
1.71
4.22
4.9
4.0
92.96
64.02
ug/l
0.93
139
1065
13
36
3.75
3.55
14.9
12.9
5.03
4.82
kpa
0.52
13
36
44
251
1.91
3.45
13.0
14.2
105.48
105.10
mmol/l
0.14
44
251
150
1201
1.60
3.33
12.9
9.1
6.10
6.27
mmol/l
0.30
141
1131
29
521
0.50
3.15
2.1
2.6
—
—
—
0
0
36
198
1.95
3.14
2.0
2.1
2.42
2.42
mmol/l
0.01
28
166
19
81
2.45
3.07
3.2
5.3
9.32
8.17
%
0.40
19
81
19
81
2.45
3.07
3.5
5.3
—
—
—
0
0
234
2133
2.13
2.98
22.0
13.5
64.38
61.08
umol/l
0.59
225
2106
12
39
3.18
2.81
6.8
4.5
17.02
17.03
%
0.01
12
39
232
2117
2.02
2.81
29.1
20.0
13.23
13.11
%
1.08
232
2100
9
23
4.02
2.80
1.2
1.1
—
—
—
0
0
28
489
0.52
2.76
1.9
2.4
—
—
—
0
0
20
94
2.22
2.62
10.9
2.7
57.78
80.85
ml/min/173m2
—
9
33
7
15
4.77
2.61
2.3
2.3
—
—
—
0
0
167
1417
1.51
2.53
6.4
5.1
8.86
6.92
mm/h
1.39
162
1345
11
37
3.06
2.52
19.0
11.9
8.34
6.62
pmol/l
0.19
11
37
33
191
1.84
2.48
1.5
1.4
180.21
173.82
u/ml
—
9
63
83
613
1.52
2.46
21.6
15.5
24.45
24.86
mmol/l
0.63
83
613
5
152
0.32
2.22
2.0
1.2
—
—
—
0
0
79
589
1.49
2.21
16.8
11.2
0.86
1.20
mmol/l
0.32
62
483
71
518
1.51
2.20
2.2
1.6
102.70
96.88
pmol/l
0.63
33
265
42
273
1.64
2.13
5.1
8.4
874.33
859.62
ng/l
0.01
37
235
17
83
2.12
2.06
2.2
5.0
600.75
501.02
e6/l
0.33
12
56
17
83
2.12
2.06
2.5
5.0
173.00
142.54
e6/l
0.44
12
57
73
545
1.47
2.01
14.7
10.7
23.53
23.66
mmol/l
0.17
73
545
16
77
2.15
2.01
2.1
5.3
28.50
26.88
%
0.19
16
77
19
98
2.01
2.01
2.2
5.4
8.14
3.92
e6/l
0.28
14
75
7
21
3.40
1.98
1.4
1.2
132.71
112.71
pmol/l
—
7
21
23
128
1.88
1.97
4.0
4.0
25.91
21.99
%
—
7
41
19
99
1.99
1.96
2.2
5.4
1206.07
201.92
e6/l
0.71
14
77
5
11
4.61
1.95
1.0
2.4
1.46
1.37
nmol/l
—
5
11
13
58
2.31
1.94
2.4
3.2
46.35
23.01
u/ml
0.62
13
58
19
100
1.97
1.91
2.0
5.3
345.42
335.03
mg/l
0.06
19
100
9
34
2.71
1.88
2.1
1.6
—
—
—
0
0
147
1259
1.39
1.84
18.5
8.9
101.33
102.74
ml/min/173m2
0.24
122
976
8
29
2.81
1.80
6.9
8.0
—
—
—
0
0
21
118
1.85
1.76
15.1
19.1
0.64
0.65
%
0.06
21
118
6
18
3.39
1.75
3.0
5.2
87.83
244.55
ug/l
—
6
18
14
68
2.12
1.73
1.2
2.0
—
—
—
0
0
7
24
2.97
1.73
8.3
10.8
—
—
—
0
0
29
181
1.68
1.72
6.0
3.8
1.14
1.36
ug/l
0.58
29
157
5
13
3.90
1.72
1.2
1.6
7.12
8.24
umol/l
—
5
13
21
119
1.83
1.72
15.1
19.0
1.00
1.14
%
0.43
21
119
10
41
2.50
1.66
3.4
1.2
300.00
365.29
mu/l
—
10
35
7
25
2.85
1.66
2.3
1.5
91.29
51.56
pmol/l
—
7
25
5
14
3.62
1.62
4.8
2.1
—
—
—
0
0
18
101
1.84
1.53
2.7
2.0
0.53
0.69
ug/l
0.87
13
43
19
109
1.80
1.51
3.8
2.3
—
—
—
0
0
17
95
1.85
1.47
2.2
1.7
—
—
—
0
0
38
265
1.51
1.45
3.8
2.3
—
—
—
0
0
214
1990
1.46
1.43
29.8
16.2
3.92
3.95
mmol/l
0.56
209
1940
5
17
2.98
1.36
1.0
1.2
360.80
268.18
mg/l
—
5
17
12
61
2.01
1.35
2.0
1.6
—
—
—
0
0
15
83
1.86
1.34
2.9
2.3
—
—
—
0
0
87
1038
0.75
1.32
1.8
2.1
—
—
—
0
0
38
272
1.47
1.29
6.6
4.2
13.54
7.42
mg/mmol
0.46
27
208
14
77
1.87
1.28
16.6
18.3
68.29
69.61
%
0.10
14
77
13
70
1.90
1.26
1.8
4.7
—
—
—
0
0
10
187
0.52
1.24
1.3
1.5
—
—
—
0
0
10
49
2.08
1.23
4.0
1.7
—
—
—
0
0
86
712
1.31
1.23
8.7
5.0
0.05
0.17
e6/l
2.05
66
525
19
118
1.66
1.18
3.3
2.1
—
—
—
0
0
156
1401
1.29
1.18
4.3
3.0
5.42
5.48
mmol/l
0.30
148
1298
11
58
1.94
1.14
2.2
3.9
0.75
0.66
e9/l
0.25
11
58
19
120
1.63
1.12
16.5
18.9
95.42
95.36
%
0.01
19
120
5
21
2.41
1.09
2.4
2.7
411.00
1356.95
u/ml
—
5
21
7
32
2.22
1.09
5.3
1.8
—
—
—
0
0
40
300
1.40
1.08
8.7
8.9
4.50
6.19
umol/l
0.83
34
252
18
114
1.62
1.06
4.1
2.5
—
—
—
0
0
34
249
1.42
1.05
20.5
16.3
1.75
1.32
mmol/l
0.48
34
239
113
986
1.26
1.04
6.4
3.9
0.00
0.01
estimate
0.50
26
169
10
53
1.92
1.02
1.7
1.3
—
—
—
0
0
114
998
1.26
1.02
6.4
4.0
0.00
0.00
estimate
-0.00
26
162
7
35
2.03
1.01
1.1
6.8
—
—
—
0
0
7
35
2.03
1.01
11.3
9.1
2.16
1.94
mg/l
—
7
27
7
35
2.03
1.01
1.1
6.8
—
—
—
0
0
59
476
1.31
1.00
6.5
3.0
0.00
0.01
estimate
0.80
23
146
7
36
1.97
0.98
1.0
1.3
—
—
—
0
0
30
219
1.42
0.95
3.5
2.3
—
—
—
0
0
59
481
1.29
0.93
6.0
4.3
0.52
0.41
e6/l
0.22
32
269
67
556
1.28
0.92
17.2
9.8
0.99
1.00
mmol/l
0.01
50
417
12
193
0.60
0.92
1.3
1.2
—
—
—
0
0
225
2151
1.38
0.90
27.5
19.5
336.43
335.38
g/l
1.01
225
2141
56
457
1.29
0.88
6.3
3.9
0.00
0.00
estimate
-0.00
27
163
11
64
1.75
0.87
3.8
2.5
—
—
—
0
0
8
139
0.56
0.86
1.1
1.1
—
44.76
—
0
14
26
189
1.42
0.85
6.3
11.6
3.03
2.83
g/l
0.34
26
182
6
31
1.96
0.85
1.0
1.1
—
—
—
0
0
57
469
1.28
0.84
6.2
4.4
3.07
1.23
e6/l
0.64
30
258
6
32
1.90
0.82
1.0
1.1
—
—
—
0
0
6
32
1.90
0.82
1.0
1.2
—
—
—
0
0
6
32
1.90
0.82
1.0
1.1
—
—
—
0
0
6
32
1.90
0.82
1.0
1.1
—
—
—
0
0
76
651
1.24
0.80
5.6
3.4
0.00
0.01
estimate
0.80
22
155
6
33
1.84
0.79
1.0
1.1
—
—
—
0
0
110
980
1.21
0.79
6.5
3.9
0.00
0.00
estimate
-0.00
27
175
0
25
0.00
0.79
0.0
1.2
—
3.14
—
0
15
0
25
0.00
0.79
0.0
1.2
—
13.10
—
0
16
43
345
1.30
0.77
3.0
2.9
14.44
46.49
ng/l
1.00
23
159
20
276
0.70
0.77
1.2
1.3
9.98
2.16
u/ml
0.67
14
219
9
54
1.69
0.75
3.8
5.0
2.58
5.19
u/ml
—
9
54
14
92
1.55
0.74
1.8
1.5
—
—
—
0
0
14
92
1.55
0.74
1.8
1.5
—
—
—
0
0
12
76
1.61
0.73
3.9
2.4
—
—
—
0
0
9
58
1.57
0.70
5.9
4.1
333.22
403.15
ug/l
—
9
53
29
223
1.34
0.70
3.3
2.2
—
—
—
0
0
20
271
0.72
0.70
1.4
2.2
—
—
—
0
0
18
248
0.71
0.69
1.1
1.3
3.39
2.57
u/ml
0.17
11
197
10
61
1.67
0.69
3.1
1.6
—
—
—
0
0
7
42
1.69
0.69
4.7
5.9
—
—
—
0
0
24
314
0.74
0.68
1.7
2.4
—
—
—
0
0
16
111
1.47
0.67
4.2
2.7
—
—
—
0
0
90
799
1.19
0.66
9.2
5.2
—
—
—
0
0
14
198
0.69
0.63
1.1
1.2
—
3.21
—
0
7
24
183
1.34
0.62
1.6
1.5
506.92
497.02
pmol/l
0.05
24
165
0
20
0.00
0.60
0.0
1.2
—
1.62
—
0
11
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
45
376
1.24
0.60
4.5
6.2
3.04
1.97
mg/l
0.45
35
283
19
251
0.74
0.58
1.2
1.3
5.45
6.60
u/ml
0.20
12
201
6
35
1.73
0.58
1.0
1.3
—
—
—
0
0
63
548
1.20
0.57
4.2
3.6
—
—
—
0
0
13
90
1.47
0.56
3.5
1.5
—
—
—
0
0
8
121
0.65
0.56
1.1
1.1
—
1.47
—
0
7
19
248
0.75
0.54
1.2
1.3
1.30
0.85
u/ml
0.47
11
189
13
93
1.42
0.49
2.3
1.3
1.24
1.19
g/l
0.23
13
87
16
120
1.36
0.47
6.2
3.2
0.10
0.10
e6/l
0.01
16
113
13
94
1.40
0.47
1.5
2.4
0.96
0.45
nmol/l
1.85
13
81
5
81
0.61
0.46
1.0
1.1
—
18.08
—
0
17
5
82
0.60
0.46
1.2
1.6
—
—
—
0
0
6
93
0.64
0.43
1.2
1.2
—
—
—
0
0
12
87
1.40
0.43
12.2
4.6
27.58
35.52
umol/l
1.27
12
87
26
213
1.25
0.43
5.2
8.4
341.85
281.31
u/l
0.35
26
208
26
314
0.81
0.43
1.1
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
3.9
—
9.88
—
0
17
0
17
0.00
0.41
0.0
3.9
—
0.00
—
0
17
7
103
0.67
0.40
2.0
1.9
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
274.22
—
0
18
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
35
1.44
0.39
1.0
1.3
—
—
—
0
0
5
36
1.40
0.38
1.0
2.1
—
—
—
0
0
5
36
1.40
0.38
1.0
1.1
—
—
—
0
0
6
43
1.40
0.35
1.3
1.2
106.83
80.51
%
—
6
43
6
44
1.37
0.34
1.3
1.0
—
—
—
0
0
6
44
1.37
0.34
1.3
1.2
—
—
—
0
0
15
118
1.29
0.34
15.6
13.6
0.44
0.60
%
1.74
15
118
12
92
1.32
0.32
2.4
1.3
0.23
0.22
g/l
0.07
12
87
128
1217
1.10
0.31
7.8
4.3
5.67
88.53
e6/l
—
6
15
14
174
0.79
0.30
2.2
1.8
—
—
—
0
0
12
93
1.30
0.30
2.0
3.4
12.20
8.25
index
—
5
61
7
56
1.26
0.29
3.4
2.5
—
—
—
0
0
25
214
1.19
0.29
7.1
14.9
107.44
94.04
%
2.36
25
214
14
113
1.25
0.27
1.3
1.4
—
—
—
0
0
50
456
1.12
0.26
3.8
3.2
1.02
1.02
kg/l
0.00
34
289
13
157
0.82
0.23
1.1
1.1
11.12
8.93
u/ml
—
8
110
8
101
0.79
0.21
1.4
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.1
—
5.99
—
0
11
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
14
166
0.83
0.21
1.1
1.2
17.12
6.71
u/ml
—
9
121
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
24.51
—
0
14
13
154
0.84
0.19
1.1
1.1
0.07
1.56
u/ml
—
6
97
12
142
0.84
0.18
2.6
1.8
—
—
—
0
0
5
69
0.72
0.17
1.0
1.5
4.27
22.49
u/ml
—
5
59
9
82
1.10
0.15
2.0
1.3
—
—
—
0
0
13
149
0.87
0.14
4.1
2.7
120.14
98.87
au/ml
—
7
68
9
110
0.81
0.13
1.0
1.5
—
—
—
0
0
10
85
1.18
0.12
1.7
1.5
—
—
—
0
0
85
825
1.05
0.09
4.7
3.8
—
—
estimate
—
0
0
10
88
1.14
0.08
3.0
4.6
—
—
—
0
0
6
73
0.82
0.07
2.0
1.8
—
—
—
0
0
32
307
1.05
0.05
2.8
4.5
1146.69
1330.72
ng/l
0.08
16
181
20
209
0.95
0.03
1.5
1.5
—
—
—
0
0
210
2108
0.98
0.01
3.9
4.1
—
—
—
0
0
217
2172
0.99
0.00
21.3
14.2
19.03
25.10
mg/l
2.96
174
1581
18
179
1.01
0.00
2.6
2.4
187.54
198.97
u/ml
0.09
13
83
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
6
61
0.98
-0.00
4.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
9.10
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
5.7
—
17.00
—
0
7
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
1.26
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: E4_ISOLATED_GROWTH_HORMONE_DEFICIENCY – Isolated growth hormone deficiency
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).